The Graphene Flagship is a Future and Emerging Technology Flagship project by the European Commission. With a budget of €1 billion, the Graphene Flagship represents a new form of joint, coordinated research on a large scale, forming Europe's biggest ever research initiative.
Launched in 2013, the Graphene Flagship’s mission is to advance graphene commercialization and take graphene and related materials from academic laboratories to society within 10 years, while revolutionizing entire industries and creating economic growth and new jobs in Europe.
The core consortium consists of about 150 academic and industrial research groups in over 20 countries. In addition, the project has a growing number of associated members that will be incorporated in the scientific and technological work packages from the Horizon 2020 phase (1 April 2016 – 31 March 2018). The project started in a ramp-up phase (October 2013 till the end of March 2016), then planned to enter into the steady-state phase (2016-2020).
The research effort covers the entire value chain from materials production to components and system integration, and targets a number of specific goals that exploit the unique properties of graphene. The Graphene Flagship is coordinated by Chalmers University of Technology, Gothenburg, Sweden.
The latest Graphene Flagship news:
The European Commission (EC) has announced a €20 million investment in the next generation of electronics and semiconductors. The 2D Experimental Pilot Line (2D-EPL) was officially launched as the first graphene foundry to integrate graphene and layered materials into semiconductor platforms. The new project aims to keep Europe at the forefront of this technological revolution.
Born within the EU-funded project, the Graphene Flagship, the 2D-EPL will cover the entire value chain, from tool producers and chemical and material providers to manufacturing lines. This collaborative project will integrate several Graphene Flagship members to pioneer the fabrication of new prototype electronics, photonic devices and sensors integrating graphene and layered materials.
A study recently conducted by Graphene Flagship partners the University of Strasbourg and CNRS, France, in collaboration with Nanyang Technological University in Singapore, has shown that graphene quantum dots are biodegradable by two enzymes found in the human body.
Graphene quantum dots (GQDs) are tiny flakes usually smaller than five nanometres that have potential for many applications. GQDs are fluorescent, so they can absorb light and then emit it, often at a different wavelength. They are also so small that they can penetrate cells. Together, these properties pave the way to a wide array of applications in bioimaging, biosensing and new therapies - among other potential uses.
An international team of researchers recently reported its success in creating a new type of graphene-based photodetector.
The team integrated three concepts to achieve the new device: metallic plasmonic antennas, ultra sub-wavelength waveguiding of light and graphene photodetection. Specifically, the 2D-material hexagonal boron nitride was used as the waveguide for hyperbolic phonon polaritons, which can highly confine and guide mid-infrared light at the nanoscale. By carefully matching the nano-antenna with the phonon polariton waveguide, they efficiently funnel incoming light into a nanoscale graphene junction. By using this approach, they were able to overcome intrinsic limitations of graphene, such as its low absorption and its small photoactive region near the junction.
The Graphene Flagship has been invited by the European Commission to create an experimental pilot line for graphene-based electronics, optoelectronics and sensors. This will be a unique experimental manufacturing facility, where European companies, research centers and academic institutions can produce novel devices based on two-dimensional (2D) materials on a pilot scale.
The goal of this endeavor is to demonstrate how to manufacture and scale up the production of devices based on 2D materials for market applications. This is a crucial step before graphene technologies can be transferred to full scale manufacturing.
INBRAIN Neuroelectronics receives funding to push forward the development of graphene-based implants for brain disorders
INBRAIN Neuroelectronics, a spin-off of the Catalan Institute of Nanoscience and Nanotechnology (ICN2), the Barcelona Institute of Science and Technology (BIST) and ICREA, has received €1 Million in funding from Sabadell Asabys and Alta Life Sciences, as well as ICF and Finaves, which will allow the company to speed up the development of novel graphene-based implants to optimize the treatment of brain disorders, such as Parkinson’s and epilepsy.
INBRAIN Neuroelectronics was established in 2019 with the mission of developing brain-implants based on graphene technology for application in patients with epilepsy, Parkinson’s, and other neuronal diseases. These smart devices, built around an innovative graphene electrode, will decode with high certainty neural signals from the brain and produce a therapeutic response adapted to the clinical condition of the specific patient.